The Title 21 Code of Federal Regulations Part 11 (21 CFR Part 11) provides compliance information regarding the U.S. Food and Drug Administration’s (FDA) guidelines on electronic records and electronic signatures. Within this part, requirements are created to help ensure security, integrity, and confidentially of electronic records and to ensure
More
Chinese pharmaceutical market is growing significantly and is going to be the
Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance
A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare
MoreSamsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin
MoreChinese pharmaceutical market is growing significantly and is going to be the world’s largest market within very few years. Many
More
The Title 21 Code of Federal Regulations Part 11 (21 CFR Part 11) provides compliance information regarding the U.S. Food and Drug Administration’s (FDA) guidelines
More
